The Conundrum of Omega-3 Fatty Acids in Cancer Prevention Studies: Which One? How Much? What Biomarkers?
Cancer Prevention Research DOI: 10.1158/1940-6207.CAPR-18-0061
Carol J. Fabian and Bruce F. Kimler
Marine omega-3 fatty acids promote resolution of inflammation and have potential to reduce risk of obesity-related breast cancer. For prevention trials in obese women, inflammatory cytokines, aromatase, and measures of breast immune cell infiltration are logical, as are biomarkers of growth factor, adipokine, and estrogen signaling. Where best to look for marker change: in the circulation (easiest), in benign breast tissue (most relevant), or in visceral adipose (inflammation often most marked)? A null biomarker modulation trial may reflect limitations in design, source and dose of fatty acids, or biomarkers and should not lead to premature abandonment of marine omega-3 fatty acids for cancer prevention. Cancer Prev Res; 11(4); 1–4. ©2018 AACR.
Clipped from PDF
“Animal model supplementation studies often first induce an inflammatory environment with a high fat diet and then administer combinations of DHA and EPA at 4% to 10% of feed by weight, usually in the range of 10% of calories for EPA and/or DHA (5, 8). Human supplementation studies with EPA and DHA, in contrast, often do not preselect for baseline inflammation and then dose in the range of 1% to 2% of calories (5). Those trials showing consistent modulation of tissue blood inflammatory biomarkers are generally in individuals with active inflammation and employ combined EPA þ DHA doses of 3.4 to 4.0 g/day or EPA or DHA alone 2.7 g/day (5, 12). There is little evidence of inflammatory biomarker modulation at doses <2 g/day”
 Download the PDF from Sci-Hub via VitaminDWiki
Thoughts by Henry Lahore, founder of VitaminDWiki
- Human studies typically use about 1% of calories of EPA and/or DHA
- Animal studies range up to 10% of calories (10X more)
- Animal studies also often use different ratios
- Animal studies also vary the dose size with weight and existing inflammation
- Wonder the improved results of RCTs if similar variations are made with human studies
- Wonder the improved results of RCTs if Omega-3 Index before/after supplementation is considered
- Note: Many health problems are associated with inflammation
- Note: There is a strong interaction/synergy between Omega-3 and Vitamin D - which is generaly ignored in most studies
Omega-3 and Inflammation (items in both categories)
- Pentadecanoic acid (C15:0), a fatty acid from grass-fed animals, is essential for human health
- Opioid addiction reduced by Omega-3 (gut inflammation in mice) – Aug 2019
- Treat wounds, stop inflammation with nanoemulsion textile of Omega-3 and Resveratrol - Sept 2019
- Inflammation is reduced by each of the following: Vitamin D, Omega-3, Diet
- Sepsis reduced the Omega-3 response and half life – April 2019
- Pollutants increase Respiratory problems, Vitamin D, Omega-3, etc. decrease them – May 2018
- Severe acute pancreatitis treated in 11 ways by Omega-3 in just 7 days – RCT April 2018
- Omega-3 treats animal inflammation better than human (those studies use higher doses and different ratios than for humans) - March 2018
- Omega-3 helps muscles and reduces inflammation, lipids, and insulin – Nov 2015
- Omega-3 improves gut bacteria, reduces inflammation and depression – Dec 2017
- Can burn pain be relieved by 4 g of Omega-3 and 2,000 IU of vitamin D – RCT due 2021
- 2.7 fewer days in hospital after surgery if had taken Omega-3 (19 RCT) – meta-analysis – June 2017
- Sepsis: 4 fewer days in ICU if add Omega-3 – meta-analysis of 12 RCT – June 2017
- Omega-3 reduces many psychiatric disorders – 2 reviews 2016
- Depression due to inflammation reduced by Omega-3 (children and pregnant) – Nov 2015
- Omega-7 - in addition to Omega-3
- Inflammation reduction through diet: Omega-3 etc. Feb 2014
- Traumatic brain injury treated by Vitamin D Progesterone Omega-3 and glutamine – May 2013
- Omega-3 reduced vitamin D3 inflammation for obese – RCT Jan 2013